预防支气管肺发育不良的药物：基线风险对所需治疗人数的影响。
Drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat.
机构信息
Division of Neonatology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
出版信息
J Pediatr. 2020 Jul;222:244-247. doi: 10.1016/j.jpeds.2020.01.070. Epub 2020 Mar 3.
Infants born very preterm have a variable baseline risk of bronchopulmonary dysplasia (BPD). Using the example of evidence-based drug therapies to prevent BPD, we designed a visual aid that displays the "number needed to treat" with CIs for caffeine, vitamin A, and hydrocortisone over a range of baseline risks.
极早产儿出生时有不同的支气管肺发育不良（BPD）基线风险。以循证药物治疗预防 BPD 为例，我们设计了一个可视辅助工具，显示了茶碱、维生素 A 和氢化可的松在一系列基线风险下的“需要治疗的人数”及其置信区间。
Zotero 插件